CellVoyant secures £7.6 million seed funding to develop stem cell therapies with AI

CellVoyant, an AI-first biotechnology spin-out from the University of Bristol accelerating the development of novel cell therapies, has announced a £7.6 million seed round.

Related Keywords

United Kingdom ,Rafaele Carazo Salas ,Uzma Choudry , ,Octopus Ventures ,Horizons Ventures ,Verve Ventures ,Air Street Capital ,Lead Biotech Investor ,Bio Developments ,Markets Amp Regulations ,Pipelines ,Emerging Markets ,Stem Cell ,Cell Biology ,Artificial Intelligence ,Hi ,